Teva Posts Q2 Loss, Cuts FY Revenues View; Reaches More Than $4 Bln Settlement Over Opioid Lawsuits
PETAH TIKVA (dpa-AFX) - An Israel-based drug manufacturer Teva Pharmaceutical Industries Ltd. (TEVA) reported a loss in the second quarter compared to profit in the prior year. It reaffirmed its
United States Teva Pharmaceutical Industries Ltd Teva Pharmaceutical Industries State Attorneys General Native American Tribes North America
Source: finanznachrichten.de